Meeting
2013 ASCO Annual Meeting
Whole-exome sequencing in tumor samples from sequenom-wild-type, ALK negative stage IV lung adenocarcinoma (ADC) patients (p).
Authors
Enriqueta Felip
Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain
Enriqueta Felip , Ginevra Caratu , Daniel Silberschmidt , Pablo Martinez , Alex Martinez Marti , Susana Cedres , Nuria Murtra-Garrell , Alejandro Navarro-Mendivil , Ludmila Prudkin , Jose Jimenez , Pilar de la Morena , Mercedes Canela , Paolo Nuciforo , Hector G. Palmer , Ana Vivancos
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Non-small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 8070)
DOI
10.1200/jco.2013.31.15_suppl.8070
Abstract #
8070
Poster Bd #
36B
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.
First Author: Michael C. Burns
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2014 ASCO Annual Meeting
Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.
First Author: Daniela Adua
Poster
2020 Gastrointestinal Cancers Symposium
Clinical utility of targeted next generation sequencing (NGS) to predict response to neoadjuvant therapy (NT) in rectal cancer (RC).
First Author: Kristen Carroll